SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Wolfgangrene's charts -- Ignore unavailable to you. Want to Upgrade?


To: wolfgangrene who wrote (1792)10/28/2015 2:29:56 PM
From: The Ox1 Recommendation

Recommended By
Justinfo

  Read Replies (1) | Respond to of 3976
 
FWIW, we rode up FOLD and took profits in 16 area.....before it ran into the first high of the double top.



To: wolfgangrene who wrote (1792)10/28/2015 3:26:31 PM
From: The Ox1 Recommendation

Recommended By
Oldbasalt

  Respond to of 3976
 
Pharma/Biotech led the market higher the past 2 years. They have been getting crushed ever since an ahole CEO marked up an HIV treatment by 1500% overnight. Caused everyone under the sun to say these stocks should be sold and in a bubble. Well, I would say that like FOLD, if it went from $2 to $18 in a little over a year, it's hard not to question the valuation process of companies in the sector.

Like Oil, Steel, Gold/Mining stocks etc.... there are plenty that deserve higher valuations but not all of them and many have come back to earth!



To: wolfgangrene who wrote (1792)7/12/2016 10:17:11 AM
From: The Ox  Read Replies (1) | Respond to of 3976
 
Possible double bottom setup....normal biotech warnings apply!